Oncologic Effects of Primary Tumor-Sidedness on Patients with Stages 1-3 Colon Cancer: A Meta-Analysis

Annals of Surgical Oncology
Gi Won HaMin Ro Lee

Abstract

Previous studies comparing the oncologic outcomes of primary tumor-sidedness for patients with colon cancer have reported a worse prognosis for those with right-sided tumors. However, most of these studies evaluated patients with metastatic disease. PubMed, EMBASE, and the Cochrane Library were searched for studies that assessed the effects of primary tumor-sidedness on survival outcomes for patients with stages 1, 2, and 3 colon cancer. The hazard ratio (HR) for primary tumor location was estimated for overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS). The inclusion criteria were met by 37 studies involving 581,542 patients. The patients with a right-sided tumor had better CSS (HR, 0.67; 95% confidence interval [CI], 0.56-0.80; p < 0.0001) among those with stage 1 cancer as well as better OS (HR, 0.89; 95% CI 0.86-0.92; I2 = 19%) and CSS (HR, 0.78; 95% CI 0.70-0.86; I2 = 78%) among those with stage 2 cancer. In contrast, among the patients with stage 3 cancer, those with a right-sided tumor had worse OS (HR, 1.12; 95% CI 1.04-1.20; p = 0.002), CSS (HR, 1.05; 95% CI 1.01-1.10; p = 0.02), and DFS (HR, 1.32; 95% CI 1.07-1.63; p = 0.008). Primary tumor location may be a prognostic factor for pat...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P JernvallP Vihko
Jun 14, 2000·BMJ : British Medical Journal·A J SuttonD R Jones
Oct 29, 2000·The American Journal of Gastroenterology·W A BleekerJ T Plukker
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Nov 27, 2004·Journal of Surgical Oncology·Pascal GervazPhilippe Morel
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PopatR S Houlston
Oct 10, 2006·The American Journal of Gastroenterology·Frank A SinicropeStephen N Thibodeau
Oct 19, 2006·Surgical Oncology·S BurtonR I Swift
Dec 7, 2007·Physiological Genomics·Lawrence C LaPointeGraeme P Young
Feb 21, 2008·Nurse Researcher·Lehana Thabane, Noori Akhtar-Danesh
Apr 22, 2008·International Journal of Epidemiology·Nikolaos A PatsopoulosJohn P A Ioannidis
Jul 16, 2008·Annals of Surgical Oncology·Robert A MeguidNita Ahuja
Aug 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Vanessa DeschoolmeesterMarc Peeters
May 1, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David HorstThomas Kirchner
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnaud D RothFred Bosman
Dec 17, 2009·Diseases of the Colon and Rectum·Frank BenedixUNKNOWN Colon/Rectum Carcinomas (Primary Tumor) Study Group
May 27, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Fariña-SarasquetaA J C van den Brule
Mar 4, 2011·Annals of Surgical Oncology·Hiroshi KatohMasahiko Watanabe
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer M WeissMaureen A Smith
Jan 10, 2012·Diseases of the Colon and Rectum·Matthew F KaladyJames M Church
Apr 18, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A G M T PowellP G Horgan
May 9, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L N van SteenbergenM L G Janssen-Heijnen
Oct 16, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J LykkeUNKNOWN Danish Colorectal Cancer Group
Dec 14, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A MerokA Nesbakken
Sep 21, 2013·Journal of the American College of Surgeons·Ana L GleisnerTimothy M Pawlik
Sep 21, 2013·Annals of Surgical Oncology·Aneel BhanguParis Tekkis
Oct 15, 2013·International Journal of Cancer. Journal International Du Cancer·Naohide OueCurtis C Harris
Jul 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E MissiagliaS Tejpar
Nov 2, 2014·Journal of the National Cancer Institute·Lindsay A RenfroUNKNOWN Adjuvant Colon Cancer Endpoints (ACCENT) Group
Aug 28, 2015·World Journal of Surgical Oncology·Elisa GilardoniLuca Gianotti
Oct 13, 2015·Nature Medicine·Justin GuinneySabine Tejpar
Nov 4, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thierry AndréAimery de Gramont
Nov 18, 2015·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Masashi YahagiYuko Kitagawa
May 27, 2016·British Journal of Cancer·Chang Gon KimSang Joon Shin
Nov 8, 2016·The Lancet Oncology·David J KerrRachel Kerr
Dec 3, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Julian Walter HolchVolker Heinemann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.